Gambaran Umum
Insulet Corporation, based in the United States, operates primarily in the medical devices industry with a focus on diabetes management technology. The company’s main innovation includes the Omnipod Insulin Management System, a revolutionary tubeless insulin pump that has significantly enhanced the convenience and management of insulin delivery for diabetics. The system is notable for its disposable pod component, which Insulet has continuously developed to improve wearability and user interface. The company’s key projects aim to expand the Omnipod's technological capabilities and its global market reach, particularly through strategic partnerships and regulatory approvals in international markets. Insulet has also been actively engaged in advancing diabetes technology with integrated continuous glucose monitoring solutions.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Insulet Corporation per 2025 Jun 30 adalah 2,359.50 MM.
- Nilai operating income untuk Insulet Corporation per 2025 Jun 30 adalah 393.90 MM.
- Nilai net income untuk Insulet Corporation per 2025 Jun 30 adalah 236.10 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 2,359.50 | 393.90 | 236.10 |
2025-03-31 | 2,198.90 | 340.80 | 402.20 |
2024-12-31 | 2,071.60 | 308.90 | 418.30 |
2024-09-30 | 1,983.90 | 318.60 | 420.90 |
2024-06-30 | 1,872.70 | 274.60 | 395.30 |
2024-03-31 | 1,780.70 | 237.70 | 234.00 |
2023-12-31 | 1,697.10 | 208.50 | 206.30 |
2023-09-30 | 1,557.00 | 120.20 | 120.00 |
2023-06-30 | 1,465.10 | 115.80 | 62.90 |
2023-03-31 | 1,368.00 | 85.30 | 0.60 |
2022-12-31 | 1,305.30 | 57.60 | 4.60 |
2022-09-30 | 1,243.30 | 127.90 | 16.80 |
2022-06-30 | 1,178.10 | 121.90 | 34.60 |
2022-03-31 | 1,141.90 | 147.60 | 44.60 |
2021-12-31 | 1,098.80 | 126.00 | 16.80 |
2021-09-30 | 1,037.20 | 69.00 | -29.50 |
2021-06-30 | 995.60 | 59.10 | -30.50 |
2021-03-31 | 958.70 | 60.30 | 8.90 |
2020-12-31 | 904.40 | 51.50 | 6.80 |
2020-09-30 | 867.70 | 76.90 | 28.90 |
2020-06-30 | |||
2020-03-31 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | 5.97 | 5.78 |
2024-09-30 | 6.01 | 5.74 |
2024-06-30 | 5.65 | 5.44 |
2024-03-31 | 3.35 | 3.31 |
2023-12-31 | 2.96 | 2.94 |
2023-09-30 | 1.72 | 1.71 |
2023-06-30 | 0.90 | 0.90 |
2023-03-31 | 0.01 | 0.01 |
2022-12-31 | 0.07 | 0.07 |
2022-09-30 | 0.24 | 0.23 |
2022-06-30 | 0.50 | 0.50 |
2022-03-31 | 0.65 | 0.64 |
2021-12-31 | 0.25 | 0.24 |
2021-09-30 | -0.44 | -0.44 |
2021-06-30 | -0.46 | -0.47 |
2021-03-31 | 0.14 | 0.13 |
2020-12-31 | 0.11 | 0.10 |
2020-09-30 | 0.45 | 0.44 |
2020-06-30 | 0.29 | 0.29 |
2020-03-31 | 0.08 | 0.09 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Insulet Corporation per 2025 Jun 30 adalah 516.20 MM.
- Nilai cash from investing activities untuk Insulet Corporation per 2025 Jun 30 adalah -136.20 MM.
- Nilai kas dari aktivitas pendanaan untuk Insulet Corporation per 2025 Jun 30 adalah -88.60 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | 516.20 | -136.20 | -88.60 |
2025-03-31 | 406.50 | -137.90 | 263.80 |
2024-12-31 | 430.30 | -146.20 | -28.10 |
2024-09-30 | 318.10 | -109.80 | 4.70 |
2024-06-30 | 275.60 | -103.10 | -10.00 |
2024-03-31 | 232.80 | -101.30 | -15.60 |
2023-12-31 | 145.70 | -119.40 | -13.60 |
2023-09-30 | 151.20 | -176.20 | -30.30 |
2023-06-30 | 151.90 | -187.50 | -27.30 |
2023-03-31 | 133.20 | -186.30 | -32.10 |
2022-12-31 | 119.00 | -191.10 | -40.30 |
2022-09-30 | 42.80 | -139.10 | -27.30 |
2022-06-30 | -39.70 | -117.40 | 18.80 |
2022-03-31 | -46.70 | -106.90 | 48.80 |
2021-12-31 | -68.10 | -82.70 | 40.70 |
2021-09-30 | -25.60 | -115.60 | 172.30 |
2021-06-30 | 44.40 | -100.70 | 140.60 |
2021-03-31 | 52.50 | -22.10 | 596.10 |
2020-12-31 | 84.00 | 14.00 | 605.50 |
2020-09-30 | 113.90 | 29.30 | 273.00 |
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 | ||
2020-06-30 | ||
2020-03-31 |
Efektivitas Manajemen
- roe untuk Insulet Corporation pada 2025 Jun 30 adalah 0.09.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | 0.09 | ||||
2025-03-31 | 0.09 | ||||
2024-12-31 | 0.09 | ||||
2024-09-30 | 0.09 | ||||
2024-06-30 | 0.09 | ||||
2024-03-31 | 0.09 | ||||
2023-12-31 | 0.09 | ||||
2023-09-30 | 0.09 | ||||
2023-06-30 | 0.09 | ||||
2023-03-31 | 0.09 | ||||
2022-12-31 | 0.09 | ||||
2022-09-30 | 0.09 | ||||
2022-06-30 | 0.09 | ||||
2022-03-31 | 0.09 | ||||
2021-12-31 | 0.09 | ||||
2021-09-30 | 0.09 | ||||
2021-06-30 | 0.09 | ||||
2021-03-31 | 0.09 | ||||
2020-12-31 | 0.01 | 0.09 | 0.00 | 0.42 | 0.05 |
2020-09-30 | 0.02 | 0.19 | 0.02 | 0.27 | 0.09 |
2020-06-30 | 0.02 | 0.07 | 0.01 | 0.44 | 0.07 |
2020-03-31 | 0.01 | 0.02 | 0.01 | 0.07 | 0.09 |
Gross Margins
- marjin kotor untuk Insulet Corporation pada 2025 Jun 30 adalah 0.64.
- marjin bersih untuk Insulet Corporation pada 2025 Jun 30 adalah 0.01.
- marjin operasi untuk Insulet Corporation pada 2025 Jun 30 adalah 0.06.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.64 | 0.01 | 0.06 |
2025-03-31 | 0.64 | 0.01 | 0.06 |
2024-12-31 | 0.64 | 0.01 | 0.06 |
2024-09-30 | 0.64 | 0.01 | 0.06 |
2024-06-30 | 0.64 | 0.01 | 0.06 |
2024-03-31 | 0.64 | 0.01 | 0.06 |
2023-12-31 | 0.64 | 0.01 | 0.06 |
2023-09-30 | 0.64 | 0.01 | 0.06 |
2023-06-30 | 0.64 | 0.01 | 0.06 |
2023-03-31 | 0.64 | 0.01 | 0.06 |
2022-12-31 | 0.64 | 0.01 | 0.06 |
2022-09-30 | 0.64 | 0.01 | 0.06 |
2022-06-30 | 0.64 | 0.01 | 0.06 |
2022-03-31 | 0.64 | 0.01 | 0.06 |
2021-12-31 | 0.64 | 0.01 | 0.06 |
2021-09-30 | 0.64 | 0.01 | 0.06 |
2021-06-30 | 0.64 | 0.01 | 0.06 |
2021-03-31 | 0.64 | 0.01 | 0.06 |
2020-12-31 | 0.64 | 0.01 | 0.06 |
2020-09-30 | 0.64 | 0.03 | 0.09 |
2020-06-30 | 0.64 | 0.02 | 0.08 |
2020-03-31 | 0.64 | 0.01 | 0.06 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1145197 |
Grupong Pang-industriya
SIC 3841 - Surgical and Medical Instruments and Apparatus |